31/12/2025
We are pleased to announce that BioLight Life Sciences Ltd. has invested in RevitalVision!
BioLight is a publicly traded company focused exclusively on ophthalmology technologies.
This investment reflects BioLight’s confidence in RevitalVision’s clinically proven technology, its team, and the significant value it brings to patients with unmet vision needs.
RevitalVision offers a non-invasive, clinically validated solution for millions of people with poor or insufficient vision who cannot improve their vision using current practices.
Recent studies have demonstrated the efficacy of RevitalVision in enhancing functional vision in cases of stable keratoconus, infantile nystagmus, adult amblyopia, post-cataract surgery, and even among elite athletes.
BioLight’s extensive experience in ophthalmology, combined with the RevitalVision team, will support broader market access and accelerated expansion of our technology across the U.S. and globally.
We look forward to this collaboration and the opportunities ahead 😊
